AR and neoplasm: Moreover, GSEA results demonstrated significant enrichments of prognostic immune signatures in tumor samples after AR signaling inhibition by enza treatment, including the Hallmark IFNγ signaling signature, the 18-gene T cell–inflamed GEP, and ICR 20-gene signatures (Fig. 5E).